Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.

TitleEffect of Aspirin on All-Cause Mortality in the Healthy Elderly.
Publication TypeJournal Article
Year of Publication2018
JournalThe New England journal of medicine
Volume379
Issue16
Pagination1519-1528
Date Published2018
ISSN0028-4793
Abstract

In the primary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial, now published in the Journal, we report that the daily use of aspirin did not provide a benefit with regard to the primary end point of disability-free survival among older adults. A numerically higher rate of the secondary end point of death from any cause was observed with aspirin than with placebo.

URLhttps://www.nejm.org/doi/10.1056/NEJMoa1803955?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
DOI10.1056/NEJMoa1803955
Short TitleN Engl J Med
X
Enter your linkblue username.
Enter your linkblue password.
Secure Login

This login is SSL protected

Loading